CNS Pharmaceuticals, Inc.·4

Feb 6, 10:28 AM ET

Mahery Amy 4

4 · CNS Pharmaceuticals, Inc. · Filed Feb 6, 2024

Insider Transaction Report

Form 4
Period: 2024-02-01
Mahery Amy
Director
Transactions
  • Award

    Option to purchase common stock

    2024-02-01+12,42012,420 total
    Exercise: $0.25Exp: 2034-02-01Common Stock (12,420 underlying)
Footnotes (2)
  • [F1]The options set forth in this table vest in 36 equal monthly installments succeeding the issuance date, or February 1, 2024, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.
  • [F2]The options were issued in connection with the reporting person's Board of Director services to the Company.

Documents

1 file
  • 4
    ownership.xmlPrimary